OTROS FARMACOS RELACIONADOS EN FASE DE INVESTIGACION

Immunotherapy for Alzheimer’s disease: from anti-β-amyloid to
tau-based immunization strategies
http://www.futuremedicine.com/doi/abs/10.2217/imt.11.170

Monoclonal antibodies against β-amyloid (Aβ) for the treatment
of Alzheimer's disease: the Aβ target at a crossroads
http://www.ncbi.nlm.nih.gov/pubmed/21501112

http://www.benthamdirect.org/pages/content.php?CAR/2011/00000008/00000008/
001AT.SGM

Solanezumab for the treatment of mild-to-moderate Alzheimer’s disease, Expert
Review of Clinical Immunology, Expert Reviews  
http://www.expert-reviews.com/doi/abs/10.1586/eci.11.93